MIFEPRISTONE

ID: ALA3188048

Chembl Id: CHEMBL3188048

Max Phase: Preclinical

Molecular Formula: C29H35NO2

Molecular Weight: 429.60

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C

Standard InChI:  InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3

Standard InChI Key:  VKHAHZOOUSRJNA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3188048

    ---

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 429.60Molecular Weight (Monoisotopic): 429.2668AlogP: 5.41#Rotatable Bonds: 2
Polar Surface Area: 40.54Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.87CX Basic pKa: 4.89CX LogP: 5.13CX LogD: 5.13
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.64Np Likeness Score: 1.23

References

1. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL..  (2019)  Mapping human microbiome drug metabolism by gut bacteria and their genes.,  570  (7762): [PMID:31158845] [10.1038/s41586-019-1291-3]